This company has been marked as potentially delisted and may not be actively trading. NASDAQ:GBSN (GBSN) (GBSN) Stock Price, News & Analysis Add Share Share Stock Analysis Stock AnalysisBuy This Stock About (GBSN) Stock (NASDAQ:GBSN) 30 days 90 days 365 days Advanced Chart Get (GBSN) alerts:Sign Up Key Stats Today's Range$0.10▼$0.1250-Day Range N/A52-Week Range$0.03▼$18.00Volume104,097 shsAverage Volume99,205 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious diseases, especially hospital-acquired infections. Its commercially available tests are clostridium difficile (C. diff) and Group B Strep. Its system includes an analyzer and a diagnostic cartridge. Each analyzer contains a module into, which individual test cartridges are placed. Its other diagnostic assays in the late stages of product development include a pre-surgical nasal screen for Staphylococcus aureus (SA), food borne pathogen panel, panel for candida blood infections, test for pertussis and a test for Chlamydia tracomatis (CT)/Neisseria gonorrhea (NG). The Company also has a pipeline of assays in an early stage of development, including respiratory testing and sepsis (blood infection) panels. It markets a platform of molecular testing in small to medium sized hospitals. Read More Receive GBSN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (GBSN) and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GBSN Stock News HeadlinesPolice close in on ‘gang behind biggest gold heist in Canadian history’April 17, 2024 | thetimes.co.ukTFEATURED: University of Kigali appoints Professor Ogechi Adeola as Deputy Vice-Chancellor – AcademicJanuary 11, 2024 | msn.comMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.August 27 at 2:00 AM | American Alternative (Ad)Blake Lively fans wowed by Seventies-inspired gold jumpsuit at New York Fashion WeekSeptember 12, 2023 | msn.comBrian Wilson so strung out on drugs he forgot he met John Lennon THREE times at same party: ‘He was toasted by demons and lost in a fog!’September 12, 2023 | msn.comAngels drop 3rd in a row to A’s as pitching, defense falterSeptember 4, 2023 | msn.comArizona volleyball wins uneven 5-setter against GCU to improve to .500 on the seasonSeptember 3, 2023 | msn.comLithuania gives Steve Kerr a bit of his own medicine as Team USA suffers their first defeat in the 2023 FIBA World CupSeptember 3, 2023 | msn.comSee More Headlines GBSN Stock Analysis - Frequently Asked Questions How were (GBSN)'s earnings last quarter? (GBSN) (NASDAQ:GBSN) announced its earnings results on Wednesday, March, 22nd. The medical research company reported ($18.25) earnings per share (EPS) for the quarter. The medical research company had revenue of $0.85 million for the quarter. When did (GBSN)'s stock split? Shares of (GBSN) reverse split on the morning of Friday, September 16th 2016.The 1-80 reverse split was announced on Wednesday, September 14th 2016. The number of shares owned by shareholders was adjusted after the market closes on Thursday, September 15th 2016. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. What other stocks do shareholders of (GBSN) own? Based on aggregate information from My MarketBeat watchlists, some other companies that (GBSN) investors own include Macrocure Ltd. - Ordinary Share (MCUR), LinnCo (LNCOQ), California Resources (CRC), (BBEPQ) (BBEPQ), BioCryst Pharmaceuticals (BCRX), (UPLMQ) (UPLMQ) and VelocityShares Daily 2x VIX Short-Term ETN (TVIX). Company Calendar Last Earnings3/22/2017Today8/26/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:GBSN CIK1512138 Webgbscience.com Phone+1-801-9901055FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NASDAQ:GBSN) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (GBSN) Please log in to your account or sign up in order to add this asset to your watchlist. Share (GBSN) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.